Gore has received CE mark approval for the 25cm Gore Viabahn Endoprosthesis with Propaten Bioactive Surface. The new 25cm Viabahn is the longest length stent graft available, designed to cover more of the lesion in the superficial femoral artery potentially reducing the need for multiple devices.
The recently redesigned Gore device features a precision laser trimming technology used to remove excess material, resulting in a contoured proximal edge that may improve flow dynamics at the proximal end. Removal of excess material at the proximal edge improves device apposition to the vessel wall when oversizing prevents device expansion to its nominal diameter. The device also incorporates the Propaten Bioactive Surface which utilises endpoint immobilisation of derivatised heparin to the endoprosthesis luminal surface. This proprietary surface technology preserves the heparin bioactive sites such that they remain free to interact with the blood at the device surface without being consumed. The original Gore Hemobahn Endoprosthesis was introduced to Europe in 1996; the Gore Viabahn Endoprosthesis with Propaten Bioactive Surface was first approved for use in the European Union in December 2008.
“In 1996, the Hemobahn-Viabahn device was the first superficial femoral artery stent graft that had good patency rates and it came already in 15cm length,” said Jacques Bleyn, vascular surgeon, Antwerp Blood-Vessel Center, Antwerp, Belgium. “Because long superficial femoral artery occlusions can be treated endovascularly with the Gore Viabahn device, Gore took this best superficial femoral artery device and made it better: heparin bonded and a new length of 25cm.”
The Viabahn Endoprosthesis is available with a low-profile delivery system that gives interventionalists a more streamlined approach to re-line the peripheral arteries. It is constructed with a durable, reinforced, biocompatible, ePTFE liner attached to an external nitinol stent structure. The excellent flexibility of the device enables it to better traverse tortuous areas of the superficial femoral artery and conform more closely to the complex anatomy of the artery.